{"id":76155,"date":"2022-01-24T16:30:40","date_gmt":"2022-01-24T16:30:40","guid":{"rendered":"https:\/\/www.atlasrleye.com\/central-retinal-vein-occlusion\/clinical-case-7\/"},"modified":"2024-02-27T23:17:09","modified_gmt":"2024-02-27T23:17:09","slug":"clinical-case-7","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/en\/oclusao-da-veia-central-da-retina\/clinical-case-7\/","title":{"rendered":"Clinical Case 7"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”RETINAL VASCULAR DISEASES” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fatlas%2F%231636632711328-9e751f35-9f1e|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Central Retinal Vein Occlusion – Clinical Case 7″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fcentral-retinal-vein-occlusion%2F|title:CENTRAL%20RETINAL%20VEIN%20OCCLUSION|”]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column]
<\/div>
<\/div>[\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”62834″ img_size=”280×250″ alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

Fundus photograph in a 50 years-old female patient,7 years after presentation of CRVO. Note the optociliary shunt vessels developed in CRVO and the arteriovenous crossing changes, (hypertensive retinopathy). VA: 20\/20 OU.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”62831″ img_size=”280×250″ alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

Note the optociliary shunt vessels developed in CRVO, in same case<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Evaluations
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=”99″ no_fill=”true” collapsible_all=”true”][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”1st Evaluation – 12 07 2006″ tab_id=”1641394922374-47016b7f-6668″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

Fundus photograph of central retinal vein occlusion in a 44-year-old female patient. The disc is edematous. There are areas of hemorrhage in all quandrants and multiple flame-shaped hemorrhages in the posterior pole. VA: 20\/100 RE; 20\/25 LE.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”57951,57948″ img_size=”251×206″ css=”.vc_custom_1708040047781{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”2nd Evaluation – 26 09 2013″ tab_id=”1643041606202-1195a575-0f51″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”57957,57954,57999,57984,57981″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”57993,57996″ img_size=”185×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”57963,57960″ img_size=”185×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”58008,58011″ img_size=”185×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”57978,57972,57969,57975″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

Seven years after presentation. He was treated with intraocular injection of bevacizumab. Note the optociliary shunt vessels developed in CRVO and the arteriovenous crossing changes (hypertensive retinopathy). VA: 20\/20 RLE.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”57987,57990,58002,58005″ img_size=”245×206″ css=”.vc_custom_1708040075695{margin-top: -30px !important;}”][vc_gallery type=”image_grid” images=”57966″ img_size=”251×250″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”3rd Evaluation – 01 02 2023″ tab_id=”1709075440623-8669d3cd-de6b”][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99084″ img_size=”185×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99088″ img_size=”185×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99100″ img_size=”251×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n

\n

BCVA: 20\/20 RE, 20\/20 LE.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”99092,99096″ img_size=”307×110″ css=”.vc_custom_1709075712489{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”RETINAL VASCULAR DISEASES” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fatlas%2F%231636632711328-9e751f35-9f1e|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Central Retinal Vein Occlusion – Clinical Case 7″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fcentral-retinal-vein-occlusion%2F|title:CENTRAL%20RETINAL%20VEIN%20OCCLUSION|”][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”62834″ img_size=”280×250″ alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text] […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":75914,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-76155","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/76155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/comments?post=76155"}],"version-history":[{"count":9,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/76155\/revisions"}],"predecessor-version":[{"id":99726,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/76155\/revisions\/99726"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/75914"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/media?parent=76155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}